Skip to content
Abierto
Menu

Solicitation

Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreak

75F40126Q00327

Food and Drug Administration, FDA Office of Acq Grant SVCS. Research and Development in Biotechnology (except Nanobiotechnology).

View on SAM.govMarkdown

Awarded

University of Liverpool

$349,994.70 obligated so far on USAspending

Description

As published on SAM.gov.

Title: Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreak Questions:

08/07/26 Responses Due: 08/10/26

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
University of Liverpool
UEI
VFHSMEHGFGG5
CAGE
U5F53
Vendor location
Liverpool
Contract
75F40126C00106, definitive contract
Obligated
$349,994.70
Actions
1 between September 2, 2026 and September 2, 2026
Competition
Not Competed, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Eo 14398 - This Project Shall Sequence and Characterize the Genome of BDBV in the Current Outbreak, with a Specific Target to Sequence and Analyze the BDBV Genome from as Many as 1,000 Patients
Match
solicitation number 75F40126Q00327 equals the FPDS solicitation identifier; same awarding office 75F401 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 4, 2026

    Solicitation

    Due August 10, 2026 at 12:00 PM EDT. SAM.gov, notice 630d874ac1f6410ca4289d1b85a3d809

Points of contact

Also open from this buyer